200
Participants
Start Date
May 31, 2016
Primary Completion Date
August 31, 2018
Study Completion Date
August 31, 2018
Nexplanon (etonogestrel contraceptive implant)
Nexplanon is a single, radiopaque, rod-shaped implant, containing 68 mg etonogestrel indicated for postpartum contraceptive use by women to prevent pregnancy. Nexplanon is designed to be effective for 3 years.
Standard postpartum contraceptive care
Condoms, Depo Provera (DMPA) or progestin-only pills initiated at any time after delivery, Nexplanon insertion at \> 4 weeks after delivery, combined hormonal contraception (e. g. pills, patch, ring) initiated at any time \> 4 weeks after delivery or levonorgestrel-intrauterine system or copper IUD insertion any time \> 6 weeks after delivery.
Magee-Womens Hospital of UPMC, Pittsburgh
Merck Sharp & Dohme LLC
INDUSTRY
University of Pittsburgh
OTHER